Health House parent becomes latest to report financial woes despite revenue growth by Steve Jones March 4, 2024March 6, 2024 Health House International parent Melodiol Global Health reported a full-year loss of more than A$52 million […]
Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience by Steve Jones and Martin Lane February 7, 2024February 7, 2024
Melodiol flags possible sale of core assets to raise capital by Steve Jones December 11, 2023December 13, 2023
Health House International delivers profitable quarter for new owner Melodiol by Martin Lane October 16, 2023October 18, 2023
Melodiol reports strong start to Q3 as Health House acquisition begins to bed down by Steve Jones July 19, 2023July 20, 2023
Creso Pharma eyes Australian market as firm seeks GMP licence by Steve Jones June 6, 2023June 6, 2023
Company news: Asterion; Ecofibre; Avecho; Epsilon Healthcare; Creso Pharma; Cann Global by Martin Lane and Steve Jones May 18, 2023May 18, 2023
Company news: Wellnex Life; Creso Pharma; MGC Pharma; Zelira Therapeutics by Martin Lane March 16, 2023March 16, 2023
Financial results: Elixinol; Emyria; Epsilon; Avecho; Creso Pharma; AusCann; MGC Pharma; Botanix; Zelira by Martin Lane and Steve Jones March 1, 2023March 1, 2023